Application of Radiomics in Breast Cancer
Launched by SECOND AFFILIATED HOSPITAL, SCHOOL OF MEDICINE, ZHEJIANG UNIVERSITY · Jul 20, 2020
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Application of Radiomics in Breast Cancer," is studying how different types of ultrasound imaging can help us understand breast cancer better. Specifically, researchers want to see how ultrasound pictures—both traditional and advanced methods—relate to important factors that can affect a patient’s prognosis (or expected outcome) after a breast cancer diagnosis. By using a technique called radiomics, which analyzes the details in these images, the study aims to find useful connections that could improve patient care.
The trial is currently looking for participants who have been clinically diagnosed with breast cancer. Anyone aged between 65 and 74 years is welcome to join, regardless of gender. However, individuals who do not have complete pathology results or follow-up data may not be eligible. If you decide to participate, you'll undergo various ultrasound tests, and your results will help researchers learn more about how imaging can predict the course of breast cancer. This information could ultimately lead to better treatment options for patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical diagnosis of breast cancer
- Exclusion Criteria:
- • Missing pathology Missing follow-up results Missing data
About Second Affiliated Hospital, School Of Medicine, Zhejiang University
The Second Affiliated Hospital of Zhejiang University School of Medicine is a leading clinical research institution dedicated to advancing healthcare through innovative medical practices and rigorous scientific inquiry. With a robust infrastructure and a multidisciplinary team of experienced researchers and clinicians, the hospital is committed to conducting high-quality clinical trials that address critical health challenges. As an integral part of Zhejiang University, the hospital leverages academic expertise and cutting-edge technology to foster collaboration in research, education, and patient care, ultimately aiming to improve patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hanzhou, Zhejiang, China
Patients applied
Trial Officials
pintong Huang
Principal Investigator
Second Affiliated Hospital, School of Medicine, Zhejiang University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials